Cancer BiologybioRxivPreprint
Therapeutic targeting of MYC- and MYCN-driven medulloblastoma with a novel MYC degrader molecule
Sin Wi Ng, Satyanarayana Gadde, Nga-yee Chung…·Glenn M. Marshall
This study identifies UNSW-SC-22 as a novel MYC/MYCN-targeting molecule that crosses the blood-brain barrier and shows potent preclinical efficacy in medulloblastoma.
DOI 10.64898/2026.07.09.737604